Figure 4From: Relieving nasal congestion in children with seasonal and perennial allergic rhinitis: efficacy and safety studies of mometasone furoate nasal sprayDaily change from baseline in AM/PM congestion score, Study 2 (PAR). Treatment difference P<.05 on all days except days 1, 2, 7, 17, 18, 20, and 29. MFNS, mometasone furoate nasal spray; PAR, perennial allergic rhinitis.Back to article page